Resource Center

Market Reports

2026 Compounding Pharmacy – Key M&A Considerations for Sellers

Compounding pharmacy remains a sector that competes on innovation, clinical value, and service—not price. Businesses that compete primarily on price[...]

More

2025 Private Equity Update – Healthcare Services & Pharmacy

Other private equity investors might acquire a target to enhance their purchasing power. For example, in the case of a[...]

More

2024 Behavioral Health LTC Pharmacy Special Report

In my 2023 Market Outlook Report I wrote about how marginalized patient populations and economic inflation can impact pharmacy values.[...]

More

2023 Compounding Pharmacy M&A Market Update – How USP 800, Semaglutide And Competitive Forces Will Shape The Industry

This year is a dynamic and fast-paced one for compounding pharmacy M&A. Early in the year, unpredictability in the broader[...]

More

2023 LTC Pharmacy Market Update – How Inflation and Marginalized Patients Will Impact Values in The Coming Years

LTC Pharmacy underwent more disruption and change in just the past few years than the preceding decades. Revenue models morphed,[...]

More

Media Releases

Harbor Healthcare Advises The Healthy Choice Compounding Pharmacy on its Sale

New York, NY – Harbor Healthcare Consultants, acting as the exclusive sell-side advisor, today announced the successful completion…

Read More

Harbor Healthcare Advises Midwest Compounders Pharmacy on its Sale

Lenexa, Kansas – Harbor Healthcare is pleased to announce the sale of Midwest Compounders, a 503A sterile compounding…

Read More

Harbor Healthcare Announces the Sale of Mercury LTC Pharmacy

Harbor Healthcare Consultants is pleased to announce it served as the exclusive sell-side advisor to Mercury Pharmacy Services,…

Read More

Harbor Healthcare Announces The Sale Of Meta Pharmacy Services

Nevada – Harbor Healthcare is pleased to announce the sale and partnership of Meta Pharmacy Services, a distinguished…

Read More

Harbor Healthcare Announces The Sale of a 50,000 sqft 503A Compounding Pharmacy

Missouri - Harbor Healthcare Mergers & Acquisitions, a leading advisory firm specializing in compounding pharmacy transactions, is pleased…

Read More

Harbor Healthcare Successfully Facilitates the Sale of Two Behavioral Health Pharmacies in California

Harbor Healthcare mergers & acquisitions, is pleased to announce the successful sale of two behavioral health pharmacies located…

Read More

Case Studies

Retail Pharmacy Case Study

Harbor Healthcare mergers & acquisitions, is pleased to announce the successful sale of two behavioral health pharmacies located…

Read More

Specialty & Home Infusion Case Study

Harbor Healthcare mergers & acquisitions, is pleased to announce the successful sale of two behavioral health pharmacies located…

Read More